When a BRCA mutation is identified, the focus of care shifts from early detection to active risk reduction. A BRCA mutation does not mean cancer is inevitable, but it does indicate a lifetime risk of developing breast (45-85%) and ovarian cancers (20-40%) by age 70. This allows for proactive and individualized decisions to reduce that risk.
Risk Reduction Pathways
There are multiple approaches to managing this increased risk. These are not one-size-fits-all decisions, but individualized strategies based on clinical assessment and patient preferences.
Enhanced Surveillance
For some individuals, close monitoring is an appropriate first step. This may include earlier and more frequent screening, typically combining mammography with MRI and ensuring imaging is done every 6 months. Surveillance aims to detect cancer at the earliest possible stage but does not reduce the underlying risk.
Risk-Reducing Breast Surgery
Risk-reducing mastectomy is an option that lowers the likelihood of developing breast cancer by 90-95%. In those mutation carriers who have already developed cancer in one breast, the risk of contralateral cancer is about 15-35%. Prophylactic surgery on the opposite side may also significantly reduce the risk of a future cancer. The surgery which involves removal of both breasts, is often combined with reconstruction, which may be done using implants or the patient’s own tissue.
Several public figures, including actors such as Angelina Jolie, Christina Applegate, Hamsa Nandini, etc. have spoken about their experiences with BRCA mutations and preventive surgery. While such decisions are highly individualized, these examples have helped increase awareness around genetic risk and risk-reducing options.
Risk-Reducing Ovarian Surgery
Prophylactic oophorectomy involves removal of the ovaries and is recommended in many cases to reduce the risk of ovarian cancer. It may also have an impact on reducing breast cancer risk by 50%. This procedure is typically considered after completion of family planning, often around the age of 35–40, though timing may vary based on individual risk factors. The effects of surgery include the onset of menopause and implications for fertility, which are important considerations in decision-making.
Support and Shared Experiences
Individuals with BRCA mutations can also benefit from support networks and patient groups. BRCA positive support groups provide essential emotional, educational and peer support for individuals navigating high risk cancer mutations. Key sources include FORCE (Facing Our Risk Of Cancer Empowered) offering online communities, and Sharsheret providing one-on-one genetic counselling support. These groups help with risk management, surgical decisions and family communication.
A Measured Approach
BRCA mutations increase risk, but they also provide an opportunity for informed and proactive care. With appropriate counseling and individualized planning, risk can be managed effectively through a combination of surveillance and, where appropriate, preventive interventions.
